GeneDx Holdings Corp.
WGS
$56.33
$4.538.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 101.30M | 117.29M | 113.52M | 99.82M | 85.76M |
| Total Other Revenue | 955.00K | 3.70M | 3.22M | 2.87M | 1.36M |
| Total Revenue | 102.25M | 120.99M | 116.74M | 102.69M | 87.12M |
| Cost of Revenue | 34.04M | 36.72M | 32.22M | 31.79M | 28.64M |
| Gross Profit | 68.21M | 84.27M | 84.53M | 70.90M | 58.48M |
| SG&A Expenses | 74.59M | 72.56M | 67.95M | 46.86M | 50.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 128.44M | 133.82M | 119.99M | 93.73M | 91.67M |
| Operating Income | -26.18M | -12.83M | -3.25M | 8.96M | -4.55M |
| Income Before Tax | -62.42M | -18.23M | -7.39M | 10.56M | -6.08M |
| Income Tax Expenses | 897.00K | -564.00K | 247.00K | -246.00K | 447.00K |
| Earnings from Continuing Operations | -63.32M | -17.67M | -7.64M | 10.81M | -6.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.32M | -17.67M | -7.64M | 10.81M | -6.53M |
| EBIT | -26.18M | -12.83M | -3.25M | 8.96M | -4.55M |
| EBITDA | -19.38M | -6.85M | 3.22M | 15.15M | 1.13M |
| EPS Basic | -2.16 | -0.61 | -0.27 | 0.38 | -0.23 |
| Normalized Basic EPS | -0.52 | -0.34 | -0.11 | 0.25 | -0.14 |
| EPS Diluted | -2.16 | -0.61 | -0.27 | 0.36 | -0.23 |
| Normalized Diluted EPS | -0.52 | -0.34 | -0.11 | 0.24 | -0.14 |
| Average Basic Shares Outstanding | 29.34M | 29.05M | 28.80M | 28.58M | 28.15M |
| Average Diluted Shares Outstanding | 29.34M | 29.05M | 28.80M | 29.75M | 28.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |